1,582
Views
0
CrossRef citations to date
0
Altmetric
Influenza – Research Article

The effectiveness of influenza vaccine among elderly Chinese: A regression discontinuity design based on Yinzhou regional health information platform

, , , , , & show all
Article: 2115751 | Received 16 Jun 2022, Accepted 18 Aug 2022, Published online: 27 Oct 2022

References

  • Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1–9. doi:10.1016/S0140-6736(17)33293-2.
  • Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA. Influenza cost and cost-effectiveness studies globally – a review. Vaccine. 2013;31(46):5339–5348. doi:10.1016/j.vaccine.2013.09.013.
  • Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, Wong JYT, Yang J, Bond HS, Wang L, et al. Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study. Lancet Public Health. 2019;4(9):e473–e81. doi:10.1016/S2468-2667(19)30163-X.
  • Cheng Y, Cao X, Cao Z, Xu C, Sun L, Gao Y, Wang Y, Li S, Wu C, Li X. Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality[J]. Ageing Res Rev. 2020;62:101124. doi:10.1016/j.arr.2020.101124.
  • Pang Y, Wang Q, Lv M, Yu M, Lu M, Huang Y, Wu J, Xie Z. Influenza vaccination and hospitalization outcomes among older patients with cardiovascular or respiratory diseases[J]. J Infect Dis. 2021;223(7):1196–1204. doi:10.1093/infdis/jiaa493.
  • Yedlapati SH, Khan SU, Talluri S, Lone AN, Khan MZ, Khan MS, Navar AM, Gulati MS, Johnson HS, Baum S, et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta‐analysis[J]. J Am Heart Assoc. 2021;10(6):e019636. doi:10.1161/JAHA.120.019636.
  • Schembri S, Morant S, Winter JH, MacDonald TM. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD[J]. Thorax. 2009;64(7):567–572. doi:10.1136/thx.2008.106286.
  • O’Reilly J, Jones MM, Parnham J, Jones M, Rudolf M. Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance[J]. BMJ. 2010;340:340. doi:10.1136/bmj.c3134.
  • Troeger CE, Blacker BF, Khalil IA, Zimsen SRM, Albertson SB, Abate D, Abdela J, Adhikari TB, Aghayan SA, Agrawal S, et al. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the global burden of disease study 2017[J]. Lancet Respir Med. 2019;7(1):69–89. doi:10.1016/S2213-2600(18)30496-X.
  • Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas R, Rivetti A. Vaccines for preventing influenza in the elderly[J]. Cochrane Database Syst Rev. 2018;2020(2). doi:10.1002/14651858.CD001269.pub6
  • Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337–344. doi:10.1093/ije/dyi274.
  • Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366(9492):1165–1174. doi:10.1016/S0140-6736(05)67339-4.
  • Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357(14):1373–1381. doi:10.1056/NEJMoa070844.
  • Anderson ML, Dobkin C, Gorry D. The effect of influenza vaccination for the elderly on hospitalization and mortality: an observational study with a regression discontinuity design. Ann Intern Med. 2020;172(7):445–452. doi:10.7326/M19-3075.
  • Van Ourti T, Bouckaert N. The Dutch influenza vaccination policy and medication use, outpatient visits, hospitalization and mortality at age 65. Eur J Public Health. 2020;30(2):275–280. doi:10.1093/eurpub/ckaa016.
  • Lopez Bernal JA, Andrews N, Amirthalingam G. The use of Quasi-experimental designs for vaccine evaluation. Clin Infect Dis. 2019;68(10):1769–1776. doi:10.1093/cid/ciy906.
  • Zhang L, Wang H, Li Q, Zhao MH, Zhan QM. Big data and medical research in China. BMJ. 2018;360:j5910. doi:10.1136/bmj.j5910.
  • Yang Y, Zhou X, Gao S, Lin H, Xie Y, Feng Y, Huang K, Zhan S. Evaluation of electronic healthcare databases for post-marketing drug saf surveillance and pharmacoepidemiology in China. Drug Saf. 2018;41(1):125–137. doi:10.1007/s40264-017-0589-z.
  • Ningbo Municipal Government. Elderly people aged70 years and older with permanent residence in Ningbo can receive free influenza vaccine; 2020.
  • Lin H, Tang X, Shen P, Zhang D, Wu J, Zhang J, Lu P, Si Y, Gao P. Using big data to improve cardiovascular care and outcomes in China: a protocol for the Chinese Electronic health Records Research in Yinzhou (CHERRY) study. BMJ Open. 2018;8:e019698. doi:10.1136/bmjopen-2017-019698.
  • Wang J, Bao B, Shen P, Kong G, Yang Y, Sun X, Ding G, Gao B, Yang C, Zhao M, et al. Using electronic health record data to establish a chronic kidney disease surveillance system in China: protocol for the China Kidney Disease Network (CK-NET)-Yinzhou study. BMJ Open. 2019;9(8):e030102. doi:10.1136/bmjopen-2019-030102.
  • Lin CY, Li D, Lu JM, Yu ZB, Zhu Y, Shen P, Tang ML, Jin MJ, Lin HB, Shui LM, et al. Short-Term associations between ambient fine particulate matter pollution and hospital visits for chronic obstructive pulmonary disease in Yinzhou District, China. Environ Sci Pollut Res Int. 2020;27(17):21647–21653. doi:10.1007/s11356-020-08448-2.
  • Huang K, Tao S, Zhou X, Mo J, Zhu B, Shen P, Lin H, Arena PJ, He N. Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou electronic health records: a population-based retrospective cohort study. Vaccine. 2020;38(18):3422–3428. doi:10.1016/j.vaccine.2020.03.013.
  • Zhou X, Lee EWJ, Wang X, Lin L, Xuan Z, Wu D, Lin H, Shen P. Infectious diseases prevention and control using an integrated health big data system in China. BMC Infect Dis. 2022;22(1):344. doi:10.1186/s12879-022-07316-3.
  • Li H, Zhao H, Lin H, Shen P, Liu C, Zhan S. Utilization of intravenous ribavirin among reproductive age adults in 2010-2017: a population-based study in the Yinzhou district, Ningbo city of China. Front Public Health. 2021;9:678785. doi:10.3389/fpubh.2021.678785.
  • Fretheim A, Soumerai SB, Zhang F, Oxman AD, Ross-Degnan D. Interrupted time-series analysis yielded an effect estimate concordant with the cluster-randomized controlled trial result. J Clin Epidemiol. 2013;66(8):883–887. doi:10.1016/j.jclinepi.2013.03.016.
  • Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, Goodacre S, Herrin J, Kerse N, McKinlay RJ, et al. A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation. J Clin Epidemiol. 2015;68(3):324–333. doi:10.1016/j.jclinepi.2014.10.003.
  • Leitmeyer K, Buchholz U, Kramer M, Schenkel K, Stahlhut H, Köllstadt M, Haas W, Meyer C. Influenza vaccination in German health care workers: effects and findings after two rounds of a nationwide awareness campaign. Vaccine. 2006;24(47–48):7003–7008. doi:10.1016/j.vaccine.2006.04.040.
  • Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521–1528. doi:10.1016/S0140-6736(14)60686-3.
  • Amirthalingam G, Andrews N, Keel P, Mullett D, Correa A, de Lusignan S, Ramsay M. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Lancet Public Health. 2018;3(2):e82–e90. doi:10.1016/S2468-2667(17)30234-7.
  • Lau WC, Murray M, El-Turki A, Saxena S, Ladhani S, Long P, Sharland M, Wong IC, Hsia Y. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine. 2015;33(39):5072–5079. doi:10.1016/j.vaccine.2015.08.022.
  • Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, et al. Interim estimates of 2016–17 seasonal influenza vaccine effectiveness – United States, February 2017. MMWR Morb Mortal Wkly Rep. 2017;66(6):167–171. doi:10.15585/mmwr.mm6606a3.
  • Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, et al. Influenza vaccine effectiveness in the United States during the 2015–2016 season. N Engl J Med. 2017;377(6):534–543. doi:10.1056/NEJMoa1700153.
  • Dawood FS, Chung JR, Kim SS, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, et al. Interim estimates of 2019–20 seasonal influenza vaccine effectiveness – United States, February 2020. MMWR Morb Mortal Wkly Rep. 2020;69(7):177–182. doi:10.15585/mmwr.mm6907a1.
  • Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine. 2013;31(50):6030–6033. doi:10.1016/j.vaccine.2013.09.063.
  • Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016;16(8):942–951. doi:10.1016/S1473-3099(16)00129-8.
  • Smetana J, Chlibek R, Shaw J, Splino M, Prymula R. Influenza vaccination in the elderly. Hum Vaccin Immunother. 2018;14(3):540–549. doi:10.1080/21645515.2017.1343226.
  • Rolfes MA, Flannery B, Chung JR, O’Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman RK, Jackson ML, Monto AS, et al. Effects of influenza vaccination in the United States during the 2017–2018 influenza season. Clin Infect Dis. 2019;69(11):1845–1853. doi:10.1093/cid/ciz075.
  • Chung JR, Rolfes MA, Flannery B, Prasad P, O’Halloran A, Garg S, Fry AM, Singleton JA, Patel M, Reed C. Effects of influenza vaccination in the United States during the 2018–2019 influenza season. Clin Infect Dis. 2020;71(8):e368–e76. doi:10.1093/cid/ciz1244.
  • Huang YD, Zhao XP, Wan T, Zhang S Effects of influenza vaccination in chronic obstructive pulmonary disease. Hai-Nan Med J. 2011;22:29–31.
  • Vasileiou E, Sheikh A, Butler C, Ferkh KE, Wissmann B, McMenamin J, Ritchie L, Schwarze J, Papadopoulos NG, Johnston S. Effectiveness of influenza vaccines in Asthma: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(8):1388–1395. doi:10.1093/cid/cix524.
  • Modin D, Jørgensen ME, Gislason G, Jensen JS, Køber L, Claggett B, Hegde S, Solomon S, Torp-Pedersen C, Biering-Sørensen T. Influenza vaccine in heart failure. Circulation. 2019;139(5):575–586. doi:10.1161/CIRCULATIONAHA.118.036788.
  • Yung RL. Changes in immune function with age. Rheum Dis Clin North Am. 2000;26(3):455–473. doi:10.1016/S0889-857X(05)70151-4.
  • Grohskopf LA, Alyanak E, Broder KR, Blanton LH, Fry AM, Jernigan DB, Atmar RL. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices – United States, 2020–21 influenza season. MMWR Recomm Rep. 2020;69(8):1–24. doi:10.15585/mmwr.rr6908a1.
  • Trucchi C, D’Amelio M, Amicizia D, Orsi A, Loiacono I, Tosatto R, Piazza MF, Paganino C, Pitrelli A, Icardi G, et al. Lowering the recommended age for the free and active offer of influenza vaccination in Italy: clinical and economic impact analysis in the Liguria region. Hum Vaccin Immunother. 2021;17(5):1387–1395. doi:10.1080/21645515.2020.1810494.
  • Seo J, Lim J, Yon DK. The impact of free vaccination policies under the Korean influenza national immunization program: trends in influenza vaccination rates in South Korea from 2010 to 2019. PLoS One. 2022;17(1):e0262594. doi:10.1371/journal.pone.0262594.
  • Fan J, Cong S, Wang N, Bao H, Wang B, Feng Y, Lv X, Zhang Y, Zha Z, Yu L, et al. Influenza vaccination rate and its association with chronic diseases in China: results of a national cross-sectional study. Vaccine. 2020;38(11):2503–2511. doi:10.1016/j.vaccine.2020.01.093.
  • World Health Assembly. Prevention and control of influenza pandemics and annual epidemics; 2003.
  • Giese C, Mereckiene J, Danis K, O’Donnell J, O’Flanagan D, Cotter S. Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: the key role of GPs in recommending vaccination. Vaccine. 2016;34(32):3657–3662. doi:10.1016/j.vaccine.2016.05.028.
  • Karki S, Dyda A, Newall A, Heywood A, MacIntyre CR, McIntyre P, Banks E, Liu B. Comparison of influenza vaccination coverage between immigrant and Australian-born adults. Vaccine. 2016;34(50):6388–6395. doi:10.1016/j.vaccine.2016.10.012.
  • Kwon DS, Kim K, Park SM. Factors associated with influenza vaccination coverage among the elderly in South Korea: the fourth Korean National Health and Nutrition Examination Survey (KNHANES IV). BMJ Open. 2016;6(12):e012618. doi:10.1136/bmjopen-2016-012618.
  • Williams WW, Lu PJ, O’Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, et al. Surveillance of vaccination coverage among adult populations – United States, 2014. MMWR Surveill Summ. 2016;65(1):1–36. doi:10.15585/mmwr.ss6501a1.
  • Ward CJ. Influenza vaccination campaigns: is an ounce of prevention worth a pound of cure? Am Econ J Appl Econ. 2014;6:38–72.
  • Nelson JC, Jackson ML, Weiss NS, Jackson LA. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol. 2009;62(7):687–694. doi:10.1016/j.jclinepi.2008.06.014.